Ivabradine, A Heart Rate Lowering Drug: A Clinical Investigation

2 Abstract: Resting heart rate is the main determinant of cardiovascular outcomes. Heart rate > 70 bpm is alarming, it leads to heart failure. Ivabradine is a specific drug of If channels to stabilize heart rate. It is the only drug with no side effects and specific mode of action. Aim of this study is to evaluate the efficacy of Ivabradine on patients. The extent of recovery is measured and checked clinically that Ivabradine is better choice for heart rate or not. A total of 146 patients were examined using Ivabradine, their medical history and the condition at the time of visit is correlated and a conclusion is made that Ivabradine is better than B-blockers both in its efficacy and cost-effectiveness. Ivabradine was proved to be a good and precise drug in reducing heart rate. Both literature and clinical investigations indicated that Ivabradine is emerging, new and best choice for heart rate stability in HF patients.